The Journal of Controlled Release is a bimonthly peer-reviewed medical journal and the official journal of the Controlled Release Society. The journal contains papers detailing research involving the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included. The journal is abstracted and indexed in BIOSIS Previews, CAB Abstracts, Chemical Abstracts, Current Contents/Life Sciences, EMBASE, MEDLINE, Science Citation Index, and Scopus.

Publisher
Elsevier
History
1984-present
Website
http://www.elsevier.com/wps/find/journaldescription.cws_home/502690/description#description
Impact factor
7.164 (2010)

Some content from Wikipedia, licensed under CC BY-SA

New nanoparticle drug combination for atherosclerosis developed

Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.

Through the kidneys to the exit

Scientists at the National University of Science and Technology "MISIS" (NUST MISIS) have identified a new mechanism for removing magnetic nanoparticles through the kidneys, which will help to create more effective and safe ...

page 1 from 3